Parkinson's disease

An international team of scientists has clarified the cause for certain genetic forms of Parkinson's disease, and has identified potential pharmacological treatments

The findings pave the way for new regenerative treatments for these diseases

Cellectricon offers fully validated in vitro disease models including human iPSC-derived neuronal cultures, cell lines, and native neuronal cultures

Researchers have mapped out the cell types behind various brain disorders, finding that cells from the gut's nervous system are involved in Parkinson's disease 

Cyclical amplification could allow doctors a 'look into the future' to pursue correct treatment